Global Natural Killer Cell Therapy Competitive Landscape Professional Research Report 2025
Research Summary
Natural killer (NK) cell therapy is a form of immunotherapy that utilizes a patient’s own or donor-derived NK cells to treat various diseases, particularly cancer. NK cells are a type of white blood cell that plays a critical role in the body’s innate immune response, specifically targeting and eliminating abnormal or infected cells. In NK cell therapy, these cells are isolated, expanded, and sometimes genetically modified in the lab before being infused back into the patient. The goal is to enhance the activity and effectiveness of NK cells in recognizing and killing cancer cells. NK cell therapy has shown promise in treating several types of cancers, including leukemia, lymphoma, and solid tumors. The therapy can be used alone or in combination with other treatments such as chemotherapy or checkpoint inhibitors. It offers the potential for targeted and personalized cancer treatment with potentially fewer side effects than traditional treatments. Ongoing research and clinical trials are exploring the optimal techniques for producing and administering NK cell therapy to improve patient outcomes and expand its application in the field of cancer immunotherapy.
According to DIResearch's in-depth investigation and research, the global Natural Killer Cell Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Kiadis Pharma, NantKwest etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Natural Killer Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Natural Killer Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Natural Killer Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Natural Killer Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Natural Killer Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Nkarta Therapeutics
Kiadis Pharma
NantKwest
Natural Killer Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Natural Killer Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Natural Killer Cell Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Natural Killer Cell Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Natural Killer Cell Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Natural Killer Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Natural Killer Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Natural Killer Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Natural Killer Cell Therapy Product by Type
- 1.2.1 NK Cell Therapies
- 1.2.2 NK Cell Directed Antibodies
- 1.3 Natural Killer Cell Therapy Product by Application
- 1.3.1 Cancer
- 1.3.2 Gastrointestinal Diseases
- 1.3.3 Others
- 1.4 Global Natural Killer Cell Therapy Market Size Analysis (2020-2032)
- 1.5 Natural Killer Cell Therapy Market Development Status and Trends
- 1.5.1 Natural Killer Cell Therapy Industry Development Status Analysis
- 1.5.2 Natural Killer Cell Therapy Industry Development Trends Analysis
- 2 Natural Killer Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Natural Killer Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Natural Killer Cell Therapy Market Analysis by Regions
- 4.1 Natural Killer Cell Therapy Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Natural Killer Cell Therapy Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Natural Killer Cell Therapy Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Natural Killer Cell Therapy Revenue Forecast by Region (2026-2032)
- 5 Global Natural Killer Cell Therapy Market Size by Type and Application
- 5.1 Global Natural Killer Cell Therapy Market Size by Type (2020-2032)
- 5.2 Global Natural Killer Cell Therapy Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Natural Killer Cell Therapy Market Size by Type
- 6.4 North America Natural Killer Cell Therapy Market Size by Application
- 6.5 North America Natural Killer Cell Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Natural Killer Cell Therapy Market Size by Type
- 7.4 Europe Natural Killer Cell Therapy Market Size by Application
- 7.5 Europe Natural Killer Cell Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Natural Killer Cell Therapy Market Size by Type
- 8.4 China Natural Killer Cell Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Natural Killer Cell Therapy Market Size by Type
- 9.4 APAC (excl. China) Natural Killer Cell Therapy Market Size by Application
- 9.5 APAC (excl. China) Natural Killer Cell Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Natural Killer Cell Therapy Market Size by Type
- 10.4 Latin America Natural Killer Cell Therapy Market Size by Application
- 10.5 Latin America Natural Killer Cell Therapy Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Natural Killer Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Type
- 11.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Application
- 11.5 Middle East & Africa Natural Killer Cell Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Natural Killer Cell Therapy Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Natural Killer Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Natural Killer Cell Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Nektar Therapeutics
- 13.1.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
- 13.1.3 Nektar Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Innate Pharma
- 13.2.1 Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Innate Pharma Natural Killer Cell Therapy Product Portfolio
- 13.2.3 Innate Pharma Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Affimed
- 13.3.1 Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Affimed Natural Killer Cell Therapy Product Portfolio
- 13.3.3 Affimed Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Chipscreen Biosciences
- 13.4.1 Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
- 13.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Glycostem Therapeutics
- 13.5.1 Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
- 13.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Fate Therapeutics
- 13.6.1 Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
- 13.6.3 Fate Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Dragonfly Therapeutics
- 13.7.1 Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
- 13.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Nkarta Therapeutics
- 13.8.1 Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
- 13.8.3 Nkarta Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Kiadis Pharma
- 13.9.1 Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
- 13.9.3 Kiadis Pharma Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 NantKwest
- 13.10.1 NantKwest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 NantKwest Natural Killer Cell Therapy Product Portfolio
- 13.10.3 NantKwest Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Natural Killer Cell Therapy Industry Chain Analysis
- 14.2 Natural Killer Cell Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Natural Killer Cell Therapy Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Natural Killer Cell Therapy Typical Downstream Customers
- 14.4 Natural Killer Cell Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook